Hussen Mansai, MD
Internal Medicine · Mankato, MNNPI 1790335446
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2022 is the largest year on record at $147, 2.3 times the $63 reported in 2019. Among internal medicine clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$71
- AstraZeneca$66
- Boehringer Ingelheim$50
- Shire North American Group Inc$40
- Johnson & Johnson$38
- AbbVie$24
- plus $39 from 2 others
What the payments were for
- Food & beverage$329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 4 | $71 |
| AstraZeneca(2 entities) | 3 | $66 |
| Boehringer Ingelheim | 3 | $50 |
| Shire North American Group Inc | 2 | $40 |
| Johnson & Johnson | 1 | $38 |
| AbbVie | 1 | $24 |
| Bayer | 1 | $20 |
| Incyte Corporation | 1 | $19 |
How this compares
$329 in reported general payments places this provider in the 90th percentile of 1,924 internal medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Mankato
- Sandeep KhosaMankato$6K
- Gregory PolandRochester$494K
- Thomas MartensBrooklyn Center$158K
- Roy ChoMinneapolis$122K
- Kamran AfzalFridley$69K
- Ekta KapoorRochester$55K
- Luke SeaburgRochester$55K
- Robert PignoloRochester$52K
- Jaskanwal Deep SaraSaint Paul$50K
- Mustafa ArainMinneapolis$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.